Sustained Revenue And ARR GrowthConsistent top‑line growth and recurring revenue expansion (21% reported, >25% CC, 7% ARR) imply improving product-market fit and a larger base of predictable revenue. This increases visibility into future cash flows, supports scale economics, and underpins long-term investment in product and sales.
Material Distribution Expansion Via Baxter GPOInclusion in a top‑10 US health system GPO and a 156+ opportunity Baxter pipeline structurally expands market access and lowers commercial friction. This partnership can provide a durable channel for enterprise conversions and accelerate penetration into large health systems over multiple years.
Operational Productivity And OpEx SavingsSustained OpEx reductions and measurable engineering productivity gains via AI/SDLC redesign improve operating leverage. Annualized >€1.4m savings plus faster delivery reduce cash burn and support margin recovery if sustained, strengthening the company's ability to scale without proportional cost increases.